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Introduction:Measurement of salivary testosterone (Sal-T) to assess androgen status offers important
potential advantages in epidemiological research.Theutility of themethoddependson the interpretation of
the results against robustly determined population distributions, which are currently lacking.
Aim: To determine age-specific Sal-T population distributions for men and women.
Methods: Morning saliva samples were obtained from participants in the third National Survey of
Sexual Attitudes andLifestyles, a probability sample survey of theBritish general population. Sal-Twas
measured using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Linear and quantile
regression analyses were used to determine the age-specific 2.5th and 97.5th percentiles for the general
population (1675 men and 2453 women) and the population with health exclusions (1145 men and 1276
women).
Results: In the general population, themeanSal-T level inmendecreased from322.6 pmol/L at 18 years
of age to 153.9 pmol/L at 69 years of age. In women, the decrease in the geometric mean Sal-T level was
from 39.8 pmol/L at 18 years of age to 19.5 pmol/L at 74 years of age. The annual decrease varied with
age, with an average of 1.0% to 1.4% inmen and 1.3% to 1.5% in women. For women, the 2.5th percentile
fell below the detection limit (,6.5 pmol/L) from age 52 years onward. The mean Sal-T level was
approximately 6 times greater in men than in women, and this remained constant over the age range.
The Sal-T level was lowest for men and highest for women in the summer. The results were similar for
the general population with exclusions.
Abbreviations: bl, lower bound; BMI, body mass index; bu, upper bound; LC-MS, liquid chromatography-tandemmass spectrometry;
Natsal, National Survey of Sexual Attitudes and Lifestyles; Sal-T, salivary testosterone; SD, standard deviation; SHBG, sex hormone
binding globulin.
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Conclusions: To our knowledge, this is the first study to describe the sex- and age-specific distributions
for Sal-T in a large representative population using a specific and sensitive LC-MS/MS technique. The
present data can inform future population research by facilitating the interpretation of Sal-T results as a
marker of androgen status.
This article has been published under the terms of the Creative Commons Attribution License (CC
BY; https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in anymedium, provided the original author and source are credited. Copyright for this
article is retained by the author(s).
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The use of saliva in the investigation of testosterone status is attractive because sample
collection is convenient, requires minimal training, and can be easily undertaken at home.
Measurement of salivary testosterone (Sal-T), therefore, offers great potential in facilitating
epidemiological and biomedical research at the population level.
Most testosterone circulating in the blood is bound to sex hormone binding globulin
(SHBG) and albumin, rendering only a small free (unbound) fraction (~1% to 2%) [1] able to
diffuse across capillaries into target tissues, where it exerts biological activity. Direct
measurement of serum free testosterone (the reference standard) is technically challenging
and expensive; hence, serum free testosterone is usually derived from mathematical
formulas using association constants of testosterone with its binding proteins [2]. However,
the relationship of calculated serum free testosterone to directly measured free testos-
terone and the clinical significance have not been universally accepted [3]. Testosterone
circulating in the body readily diffuses across capillaries and salivary ducts, resulting in a
salivary fraction containing free unbound testosterone [4]. Measurement of Sal-T might
thus provide an alternative to measuring serum total testosterone, free testosterone, or
bioavailable testosterone in the assessment of androgen status. Concerns have been raised
regarding the reliability of Sal-T measurement using immunoassay methods [5]. However,
recent methodological advances have allowed Sal-T to be reliably and accurately measured
using more specific and sensitive liquid chromatography tandem mass spectrometry (LC-
MS/MS) [6–8]. In bothmen andwomen, Sal-T correlates well with the calculated serum free
testosterone level [8] and does not correlate with SHBG [9]. A high correlation between Sal-
T and serum free testosterone measured by equilibrium dialysis in both men and women
has also been confirmed; however, a substantial systematic positive bias was present in
women, which might reflect the influence of salivary protein binding to the lower female
concentrations of Sal-T [8]. Whether Sal-T can be a surrogate for circulating free testos-
terone or a valid measure of tissue bioavailable testosterone can now be investigated
further.
Application of Sal-T measurements for the assessment of androgen status in men and
women is critically dependent on the interpretation of results against rigorously de-
termined age-specific population distributions. Using relatively small numbers of
samples from hospital personnel or clinic attenders for this purpose is convenient but
problematic owing to inherent selection bias and inadequate statistical power. Pop-
ulation ranges based on probability samples are more representative of the general
population. They have only become available recently for serum testosterone mea-
surements in both men [10] and women [11] and, as yet, have not been widely used. The
present study aimed to determine the age-specific population distributions for Sal-T in a
large sample of adult men and women from the general population in Britain using a
highly sensitive and specific LC-MS/MS method. We have provided population distri-
butions for the general population with exclusions (excluding those with self-reported
medical conditions or using medications that can alter the testosterone levels) and the
general population across the full age range to maximize its usefulness for a broad range
of research studies.
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1. Methods
A. Study Population
The third National Survey of Sexual Attitudes and Lifestyles (Natsal-3) is a stratified
probability sample survey of 15,162 men and women aged 16 to 74 years and resident in
Britain, which used the postcode address file as its sampling frame. Participants were
interviewed between September 2010 and August 2012 using computer-assisted personal
interviewing, including a computer-assisted self-interview for the more sensitive questions.
The response rate was 57.7%. Full details of themethods used have been described previously
[12, 13].
After the interview, a subsample of men and women aged 18 to 74 years, who did not
regularly work night shifts, were invited to provide a saliva sample to test for tes-
tosterone, without a return of the results. Consenting participants were given a self-
collection pack and asked to provide their sample before 10 AM to minimize the diurnal
variation in testosterone [7]. They were asked not to brush their teeth, eat, or chew
before giving the sample and to spit directly into a plain polystyrene tube. The saliva
samples were posted to the laboratory, where they were prepared and frozen at 280°C
until analysis [7]. On receipt of the sample, the participants were sent a £5 voucher as a
token of appreciation.
Of 13,431 participants aged 18 to 74 years who did not regularly work at night, 9170
were invited to provide a saliva sample. A total of 4591 samples were received andmatched
to the survey data (50.1% of those invited to provide a sample). Of the samples, 463 (10.1%)
were excluded (insufficient volume, n = 154; sample discolored or bloody, n = 91; sample
recorded as taken after 10:30 AM, n = 34; .5 days between the sample being taken and
received by the laboratory or interval unknown because date of collection missing, n = 172;
and not tested because of error, n = 12), leaving 4128 samples (45.0%) with a testosterone
result.
The analysis for the general population included all 4128 participants (1675men and 2453
women) with usable testosterone results. To generate the distribution for a general pop-
ulation with exclusions (those who did not report health conditions or taking medication that
can influence testosterone levels), 530 men and 1177 women were excluded from analysis
(individuals could be excluded for.1 reason). The reasons included prostate cancer (13 men),
prostate enlargement (90men), prostate surgery (20men), and polycystic ovaries (35women).
The exclusions also included treatment of any of the following in the previous year: cancer, 25
men and 49 women; thyroid conditions, 27 men and 183 women; testicular or pituitary
conditions, 16 men; and ovarian or pituitary conditions, 23 women. Also, we excluded par-
ticipants if theywere taking prescriptionmedication for epilepsy (15men and 15women), had
undergone hysterectomy and were taking hormone replacement therapy (to indicate oo-
phorectomy; 181 women), and because of unprompted reported use of testosterone (1 man).
We did not ask participants directly regarding their use of testosterone. Additionally, we
excluded 363 men with a body mass index (BMI) ,18.5 or .30 kg/m2 and 118 women with a
BMI ,18.5 or .40 kg/m2. Women reporting the current use of either hormonal replacement
therapy (62women) or hormonal contraception (pill, intrauterine device, injections, implants,
or patch; 535 women) and those who were currently pregnant (42 women) were also excluded.
Finally, those who did not answer any of the above questions were excluded (42 men and 134
women), leaving 1145 men and 1276 women for the analysis of the general population with
exclusions.
B. Measurements
The LC-MS/MS Sal-T assay was developed using strict validation criteria [7, 14]. Sample
preparation using liquid–liquid extraction entailed adding sample (200 mL), D5-testosterone
internal standard (10 mL; 340 pmol/L), andmethyl-tert-butyl ether (1 mL). After vortexing
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for 5 minutes, the organic layer was transferred and evaporated and the residue recon-
stituted with a 500-mL/L methanol mobile phase (80 mL) and transferred to a 96-well
microtiter plate.
Liquid chromatography was performed with an ACQUITY Ultra Performance Liquid
Chromatography system coupled to a Xevo TQ-S mass spectrometer (Waters Corporation,
Manchester, UK) operated in positive ionization mode. The lower limit of quantification was
6.5 pmol/L, and the assay was linear to $52,000 pmol/L. The interassay coefficient of var-
iation6 standard deviation (SD) and bias was 12.9%6 1.7% and 1.2%; 9.8%6 2.5% and 0.4%;
and 4.5%6 12.0% and 1.9% at a concentration of 12.9, 26.0, and 260 pmol/L, respectively. The
intra-assay coefficient of variation6SDand biaswas 9.5%6 1.3% and 0.8%; 5.5%6 1.6% and
12.6%; and 2.1% 6 6.2% and 11.1% at a concentration of 12.9, 26.0, and 260 pmol/L, re-
spectively. Recovery was 104% (range, 98.3% to 108.9%) [7].
C. Statistical Analysis
Statistical analyses were performed using STATA, version 13.1 (StataCorp, College Station,
TX), accounting for the complex survey design (stratification, clustering, and weighting of the
sample). We applied 2 weights when analyzing the data. The survey weight corrected for
unequal probability of selection and differential response (by age, sex, and region) to the
survey itself, and the saliva weight corrected for unequal probability of selection and dif-
ferential response to the saliva sample. A number of factors were associated with providing a
sample, including age at interview, ethnicity, general health, and sexual function measured
using theNatsal sexual function questionnaire [15]. The full details of theseweights and their
calculation have been previously reported [12].
We used 2 statistical approaches to estimate the 2.5th to 97.5th percentiles for the pop-
ulation distributions for Sal-T levels in men and women: linear regression and quantile
regression, as previously reported for calculating the serum testosterone reference ranges [10,
11]. Both analyses were performed to produce the distribution limits for the general pop-
ulation and the general population with exclusions.
Linear regression, as a parametric technique, can be unduly affected by extreme values.
Therefore, very high Sal-T values were censored such that for each 10-year age group
stratified by sex, values greater than the 99th percentile were replaced by the 99th percentile
(17men and 26women). The 99th percentile values ranged from 587.4 pmol/L in the youngest
men to 352.6 pmol/L in the oldest men and from 233.2 pmol/L in the youngest women to 104.6
pmol/L in the oldest women, respectively. The Sal-T data for men were approximately
normally distributed; however, the distribution for womenwas skewed. Thus, the valueswere
transformed on the natural log scale for analysis and back-transformed to generate the final
population distribution limits. Because quantile regression is a nonparametric approach, it
was not necessary to censor the extreme high values of Sal-T or to transform the data for the
women.
Three men (all aged.60 years, all included in the general population with exclusions) and
76 women (distributed across the 18 to 74-year age range, 33 of whom were included in the
general population with exclusions) had Sal-T levels less than the limit of detection (,6.5
pmol/L). Interval regression was used, assigning these cases to the range of 0 to 6.5 pmol/L for
the linear regression for men. The lower bound for the women was set as 0.5 to allow the
values to be log transformed. For quantile regression, these cases were assigned a value of
3.25 pmol/L (one-half the limit of detection).
For bothmen andwomen, the SD of Sal-Twas not constantwith age. Therefore, after fitting
the linear regression for the mean values, we calculated the SD of the Sal-T levels for each
year of age and used these values as the outcome in a second linear regression analysis to
predict the SD as a function of age. The predicted 2.5th and 97.5th percentiles for each year of
age were calculated as the predicted mean Sal-T minus the predicted SD for that age
multiplied by the lower bound (bl) and the predictedmean plus the predicted SDmultiplied by
the upper bound (bu), respectively, with bl and bu selected such that across all ages, 2.5% of the
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population had testosterone values less than the lower bounds and 2.5% of the population had
testosterone values greater than the upper bounds. We tried different values for each
multiplier, bl and bu, starting with 1.96, which corresponded to the normal distribution, and
iteratively increasing or decreasing the values until we achieved the desired coverage. For
men in the general population, the values were bl of 2.00 and bu of 2.30, and for women in the
general population, they were bl of 2.11 and bu of 1.96. The values for the men in the general
population with exclusions were bl of 2.09 and bu of 2.25, and for women, bl of 2.10 and bu
of 1.96.
Formen, the SD of Sal-T decreasedwith age up to a point (fromapproximately age 70 years)
and increased again in the oldest age group. We were unable to adequately model this in-
crease in the SD to accurately calculate the 2.5th and 97.5th percentiles (which are based on
the SD) and consequently truncated the population distribution analysis formen at age 69.No
equivalent increase in the SD was found among older women; therefore, the data are pre-
sented for the full age range, 18 to 74 years. Truncation was not necessary for the analysis of
the mean testosterone levels, including associations with seasonal changes.
To allow for a possible nonlinear relationship between Sal-T and age, we explored 2 dif-
ferent functions of age (in addition to a linear function) in both the linear and the quantile
regression analyses: a quadratic function and a restricted cubic spline function. For the latter,
3 knots were specified at the 10th, 50th, and 90th percentiles of age (the default placement for
3 knots). The population distribution produced by the models using the quadratic and cubic
spline functions was similar; therefore, we opted to use the simpler quadratic function in the
final models. For women, the analyses were performed on log-transformed data and the data
were back-transformed; therefore, the geometric mean values are presented.
To assess the seasonal variation in testosterone, the mean (geometric mean for women)
testosterone and 95% confidence intervals were plotted by season for the general population,
and linear regression was used to test for differences. Each season was defined as winter
(December, January, and February), spring (March, April, and May), summer (June, July,
and August), and autumn (September, October, and November). To explore potential geo-
graphical differences, the participants were grouped into 3 broad regions of residence:
Scotland and North of England, Midlands and Wales, and East and South of England (in-
cluding London).
D. Ethics Statement
The Oxfordshire Research Ethics Committee A approved Natsal-3 (reference no. 09/H0604/
27). All participants provided written informed consent for anonymized testing of the saliva
samples, without a return of the results.
2. Results
Distributions of the mean6 SD and median and interquartile range of the Sal-T levels in the
general population by 10-year age group are listed in Table 1 and for the general population
with exclusions in Supplemental Table 1. The Sal-T levels for both men and women showed a
distinct age-related decline, with a clear demarcation in the mean levels between men and
women. The mean Sal-T concentration was approximately 6 times greater in the men than in
thewomen; this relationship remained constant over the 6 decades studied in both the general
population and the general population with exclusions (Table 1; Supplemental Table 1).
The Sal-T distributions according to the linear and quantile regression analyses for men
andwomen in the general population are shown in Fig. 1. For bothmen andwomen, the linear
and quantile regression analyses produced similar population distributions. Supplemental
Table 2 shows the age-specific values for the 2.5th and 97.5th percentiles of the distribution
for the general population produced by the linear regression (those produced by quantile
regression analysis not shown). The Sal-T distributions for men and women in the general
populationwith exclusions are shown in Supplemental Fig. 1, and the values for the 2.5th and
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97.5th percentiles of the distribution are listed in Supplemental Table 2. Forwomen, the 2.5th
percentile fell below the limit of detection (,6.5 pmol/L) from age 52 years onward in the
general population and age 54 years onward in the general population with exclusions; thus,
these data are not provided.
The range of Sal-T values greater than the 97.5th percentile amongwomen aged,55 years
was wide; however, for those aged .55 years, most of the high values were clustered just
above the 97.5th percentile line (Fig. 1). Although detailed information on menstrual phase
was not collected, our questionnaire enabled the identification of women who had provided
saliva sampleswithin 7 days of starting their lastmenstrual period (presumed early follicular
phase). Very few of the high values in the premenopausal women were among those in the
early follicular phase (data not shown), suggesting that they might ay reflect mid-cycle
testosterone peaks [16].
For the full age range examined, the mean Sal-T levels decreased by approximately 50% to
60% in both the general population with exclusions and the general population of men and
women. Because our models of the association between Sal-T and age included a nonlinear
function of age, the predicted year-by-year decline in testosterone varied by age. For men in
the general population, the predicted decrease in the average Sal-T level for each year of age
was 1.3% to 1.5%. The predicted decline between age 18 and 19was 1.4% (range, 322.6 to 318.0
pmol/L), between age 45 and 46 was 1.5% (range, 216.9 to 212.7 pmol/L), and between age 68
and 69 was 1.3% (range, 156.0 to 153.9 pmol/L). For women in the general population, the
predicted decrease in the average Sal-T level for each year of agewas 1.0% to 1.4%. The decline
between age 18 and 19was 1.0% (range, 39.8 to 39.4 pmol/L), between age 45 and 46was 1.4%
(range, 28.9 to 28.5 pmol/L), and between age 73 and 74was 1.0% (range, 19.7 to 19.5 pmol/L).
Seasonal differences in the mean Sal-T levels were observed (P, 0.0001 for both men and
women; Fig. 2); however, these differed by sex, with the lowest levels in the summer for men
and the highest levels in the summer for women. We found no associations between the mean
Sal-T level and the broad geographical region (P = 0.2432; Fig. 2).
3. Discussion
To our knowledge, the present study is the first to establish age-specific population distri-
butions for LC-MS–analyzed Sal-T in men and women from a large general population
sample. Our findings showed only a minor overlap between the age-specific male and female
Table 1. Mean and Median Salivary Testosterone by Age Group and Sex in General Population
Variable
Sal-T (pmol/L) Denominator
Mean 6 SD Median (IQR) UWt Wt
Men
18–24 314.8 6 111.6 314.9 (246.3–384.1) 187 244
25–34 266.7 6 102.5 264.6 (198.6–325.9) 249 335
35–44 232.6 6 91.5 229 (178.4–285.3) 244 376
45–54 207.5 6 80.2 203.2 (155.3–248.9) 305 397
55–64 174.4 6 64.7 175.9 (130.6–214.9) 347 350
65–69 157.6 6 58.5 152.0 (119.3–190.1) 194 153
Women
18–24 51.1 6 45.1 39.2 (21.7–65.6) 247 268
25–34 42.6 6 32 37.1 (24.3–49.6) 441 403
35–44 41.1 6 31.7 32.4 (21–50.7) 425 414
45–54 33.9 6 28.5 26.6 (17.9–40.5) 451 430
55–64 27.6 6 18.6 22.9 (15.3–35.8) 462 368
65–74 27.5 6 20.2 23.2 (14.8–33.2) 427 284
Abbreviations: IQR, interquartile range (25 to 75th percentiles); UWt, unweighted; Wt, weighted.
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population distributions, mirroring those seen with serum testosterone, and lending support
to the validity of our Sal-T measurements. The finding of sixfold greater Sal-T levels in the
men compared with the women was also similar to that observed for serum testosterone [17],
reflecting the markedly greater daily testosterone blood production rate in men [18]. A
distinct age trend in Sal-T levels was observed in both sexes. The rate of cross-sectional
decline in Sal-T with age was similar to the decline in Sal-T with age in other smaller studies
of men [19–21] and women [20] but greater than the reported decline in serum testosterone in
men [22–24] and women [11, 25, 26].
The age-associated decline in serum testosterone has been implicated in a variety of
physiological changes in agingmen [27, 28]. However, this has been disputed by some [29, 30],
who have suggested that the apparent decline is largely due to comorbidity, with healthy
elderly men showing little change in their circulating testosterone levels. Although we found
that men aged .45 years who had not reported any of the exclusion health conditions had
slightly greater levels of Sal-T compared with the whole sample, the Sal-T levels in thesemen
had nevertheless decreased by one-half from age 18 to 69 years. This suggests that the widely
reported serum total and free testosterone decreases during the life course of 17% and 35%,
Figure 1. Distribution of salivary testosterone in (A) men and (B) women in the general
population. Curves created using linear regression (solid line) for the fitted mean (men) or
geometric mean (women) for the 2.5th and 97.5th percentiles and quantile regression (dashed
line) for the median, 2.5th percentile, and 97.5th percentile. Observed values (x) for 1526 men
and 2543 women displayed.
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respectively [22–24], might underestimate the aging-associated decline in testicular function
or testosterone bioavailability at the tissue level. An important corollary of this compelling
age trend in Sal-T is to reinforce the view that a Z-score approach, using age-specific pop-
ulation ranges, might be more appropriate and physiologically meaningful than the pre-
viously preferred testosterone score approach using comparisons with ranges derived from
young (age ,40 years) healthy men [10].
In premenopausal women, we observed some extreme high values of Sal-T, extending far
above the 97.5th percentile, which possibly reflected the midmenstrual cycle peaks in tes-
tosterone [16, 26, 31].Wedid not collect detailed information on themenstrual phase; thus, we
were unable to control for variations in testosterone across the menstrual cycle in our
analysis. In broad agreement with the serum testosterone levels from other large population-
based studies [11, 25, 26], we found that the decline in Sal-T in women was steepest in the
early reproductive years and subsequently flattened out in midlife. In agreement also with
the serum testosterone findings from other studies [11, 26, 32], we did not observe a sub-
stantial effect of the menopausal transition on Sal-T levels. The percentage of change in
serum testosterone previously found in healthy women aged 20 to 60 years was 30% [11]. In
contrast, the percentage of change in Sal-T in our study was ;60% for a similar age range.
Thus, just as inmen, the age-related decrease in Sal-T levels in womenwho did not report any
of the exclusion health conditions was appreciably greater than that observed for serum
testosterone. The principal sources of androgens in postmenopausal women are the adrenal
gland and the ovary [33]. An increase in free testosterone could also arise from a relative
decrease in SHBG compared with testosterone, a finding consistent with the trend of de-
creasing SHBG across the menopausal transition [34].
The seasonal variation in Sal-T observed in men showed the opposite trend to that seen in
women, with an increase in the summer and a decrease in the winter in women. Previous
studies examining seasonal variations in serum testosterone levels in men and women have
yielded inconsistent results, with either no seasonal variation found [35] or with peak levels
Figure 2. Mean (men) and geometric mean (women) salivary testosterone (pmol/L) by season
[(A), men; (B) women] and region [(C) men; (D) women] in the general population.
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found in the winter [36] or the summer [37]. In the only Sal-T study, peak levels were found in
October and December for the women and men, respectively [38]. Although statistically
significant, the magnitude of the observed seasonal differences in Sal-T was relatively small
(~20 pmol/L in men and ~8 pmol/L in women), and the variation might not be biologically or
clinically important. Given these inconsistencies, we do not believe it would be appropriate to
provide separate Sal-T population distributions stratified by season.
Natsal-3 is broadly representative of the British population, including in terms of ethnicity
[13], but was not designed specifically to examine ethnic variations in testosterone. We found
no association with the broad geographical regions, which is perhaps unsurprising given that
Britain is a small country in terms of area and previous research into geographical variation
has been on a global scale [39].
The strengths of the present study are the large general population sample size, the state-
of-the-art LC-MS/MSmeasurement of Sal-T, and the rigorous statistical analysis techniques.
To enable the fullest application in future investigations, we established population distri-
butions, not only for the entire general population, but also after exclusion of conditions and
medications that can affect Sal-T levels. This ensured applicability of the presented in-
formation to a wide range of epidemiological and biomedical studies in the future.
The present study also had some limitations. The health conditions were self-reported, and
single morning saliva samples cannot account for intraindividual variations resulting from
circhoral, diurnal, and circannual rhythms. The lack of accurate information on the timing of
samples in relation to the menstrual cycle and clinical information on the presence of
polycystic ovarian syndrome among women could have introduced added “noise” in the
distributions. Although our samplewas similar to the censuswith respect to ethnicity, health,
and marital status after weighting [12, 13], just as with any general population survey, our
data were susceptible to some participation biases. For instance, individuals in residential or
nursing care were not included in the sampling frame, and poor health could have affected
subjects’ willingness to participate (i.e., our population distributions for the general pop-
ulation might refer to a slightly healthier sample than the true British general population).
The final response rate to the saliva study was 45%; therefore, the saliva data were weighted
during analysis to minimize the potential for a nonresponse bias [12].
Age- and sex-specific population distributions are important as a baseline against which
other analyses and research studies can be compared. The array of background information,
in particular, with respect to age and BMI, will be important when considering important
research questions, such as the variations in Sal-T at the population level with respect to the
frequency of sexual activity at the extremes of the age spectrum, sexual satisfaction, and
number of sexual partners. Some of these questions are being addressed in our ongoing
analyses.
The presented data describe the distribution of Sal-T in the general population as part of a
large study to investigate the determinants of variations in sexual lifestyle and practices in
men and women. The information is not intended to be applied to the clinical setting (without
further stringent clinical evaluation), particularly with respect to hormone replacement
therapy for older individuals. The very clear decline in Sal-T levels with age lends support to
the view that lower testosterone levels are a physiological change and argue against the use of
hormone replacement therapy for older individuals.
We have determined age-specific population distributions for Sal-T in a large, represen-
tative population of men and women using a highly specific and sensitive LC-MS/MS
technique. The relative simplicity of saliva collection has important implications for large
population-based studies, in which serum collection has been impractical or too expensive.
These population data, which can be harmonized with those from other laboratories using
validated LC-MS/MS methods, provide a benchmark for ensuring the appropriate in-
terpretation and comparisons of Sal-T results in future research. An essential step has now
been taken to allow the application of Sal-T levels in investigating the potential importance of
androgen exposure in many aspects of sexual behavior and general health in largescale
population surveys of men and women.
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